Metronomia news

01
Feb
2012

New version of IWRS released

We are proud to announce that a new version of our in-house developed interactive web response system was released last month.  

Read more …

24
Jan
2012

First US site initiated

The first US site ever was activated for using an eCRF provided by Metronomia in a multinational phase II leukemia trial. 

Read more …

02
Jan
2012

All the best for 2012!

Metronomia wishes you - our customers, partners and visitors - a prosperous and Happy New Year 2012.
We are looking forward to continuing our successfull collaboration in 2012.

Read more …

25
Nov
2011

25.11.2011: Application of propensity score based matching in oncology

Today Metronomia has delivered the statistical report for an indirect comparison of data from a single arm trial in oncology with a historical dataset based on ...  

Read more …

23
Nov
2011

23.11.2011: Critical market access trial in COPD awarded to Metronomia

Today a multinational pharmaceutical customer awarded a critical  market access trial in COPD to Metronomia.

Read more …

12
Aug
2011

12.08.2011: Business Development- eCRFs outperforms paper-CRFs

It' the first time that we at Metronomia see more eCRF project being abwarded to Metronomia than paper-CRF trials. 

Read more …

15
Jul
2011

05.07.2011: Metronomia Social Day

On the 5th of July, Metronomia spent a day working in an asylum-seekers' hostel in Munich.

Read more …

29
Mar
2011

Meet us at the European Clinical Data Forum!

Metronomia is sponsoring the "European Clinical Data Forum", 24 - 25 May 2011 in Munich, Germany.This event bundles two conferences: "eClinical Trials" and "Clinical Data Management", both representing Metronomia’s core business. We are looking forward to welcome you at our booth!

Read more about this event: http://www.arena-international.com

Read more …

24
Mar
2011

Study with innovative stem cell therapy in PAOD initiated in March 2001

Metronomia is providing monitoring, data management and statistical services for a randomized phase II study with innovative stem cell therapy in patients suffering from peripheral arterial occlusive disease. 

Read more …

21
Mar
2011

Contracts with several new bio-pharmaceutical customers signed

During the last three months contracts with three new bio-pharmaceutical and biotech customers were signed. These customers develop therapies mainly in oncology and dermatology (amongst other indications).

Read more …